Lysine 68 acetylation directs MnSOD as a tetrameric detoxification complex versus a monomeric tumor promoter

Yueming Zhu, Xianghui Zou, Angela E. Dean, Joseph O’ Brien, Yucheng Gao, Elizabeth L. Tran, Seong Hoon Park, Guoxiang Liu, Matthew B. Kieffer, Haiyan Jiang, Melissa E. Stauffer, Robert Hart, Songhua Quan, Karla J. F. Satchell, Nobuo Horikoshi, Marcelo Bonini, David R Gius*

*Corresponding author for this work

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Manganese superoxide dismutase (MnSOD) functions as a tumor suppressor; however, once tumorigenesis occurs, clinical data suggest MnSOD levels correlate with more aggressive human tumors, implying a potential dual function of MnSOD in the regulation of metabolism. Here we show, using in vitro transformation and xenograft growth assays that the MnSOD-K68 acetylation (Ac) mimic mutant (MnSODK68Q) functions as a tumor promoter. Interestingly, in various breast cancer and primary cell types the expression of MnSODK68Q is accompanied with a change of MnSOD’s stoichiometry from a known homotetramer complex to a monomeric form. Biochemical experiments using the MnSOD-K68Q Ac-mimic, or physically K68-Ac (MnSOD-K68-Ac), suggest that these monomers function as a peroxidase, distinct from the established MnSOD superoxide dismutase activity. MnSODK68Q expressing cells exhibit resistance to tamoxifen (Tam) and cells selected for Tam resistance exhibited increased K68-Ac and monomeric MnSOD. These results suggest a MnSOD-K68-Ac metabolic pathway for Tam resistance, carcinogenesis and tumor progression.

Original languageEnglish (US)
Article number2399
JournalNature communications
Volume10
Issue number1
DOIs
StatePublished - Dec 1 2019

Fingerprint

acetylation
Acetylation
Detoxification
inorganic peroxides
lysine
Carcinogens
Lysine
Superoxide Dismutase
manganese
tumors
Tamoxifen
Tumors
Carcinogenesis
cells
suppressors
Neoplasms
metabolism
Metabolic Networks and Pathways
Heterografts
Metabolism

ASJC Scopus subject areas

  • Chemistry(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Physics and Astronomy(all)

Cite this

Zhu, Yueming ; Zou, Xianghui ; Dean, Angela E. ; Brien, Joseph O’ ; Gao, Yucheng ; Tran, Elizabeth L. ; Park, Seong Hoon ; Liu, Guoxiang ; Kieffer, Matthew B. ; Jiang, Haiyan ; Stauffer, Melissa E. ; Hart, Robert ; Quan, Songhua ; Satchell, Karla J. F. ; Horikoshi, Nobuo ; Bonini, Marcelo ; Gius, David R. / Lysine 68 acetylation directs MnSOD as a tetrameric detoxification complex versus a monomeric tumor promoter. In: Nature communications. 2019 ; Vol. 10, No. 1.
@article{2ad654cc0c1c4f3e9e615225541dc5ba,
title = "Lysine 68 acetylation directs MnSOD as a tetrameric detoxification complex versus a monomeric tumor promoter",
abstract = "Manganese superoxide dismutase (MnSOD) functions as a tumor suppressor; however, once tumorigenesis occurs, clinical data suggest MnSOD levels correlate with more aggressive human tumors, implying a potential dual function of MnSOD in the regulation of metabolism. Here we show, using in vitro transformation and xenograft growth assays that the MnSOD-K68 acetylation (Ac) mimic mutant (MnSODK68Q) functions as a tumor promoter. Interestingly, in various breast cancer and primary cell types the expression of MnSODK68Q is accompanied with a change of MnSOD’s stoichiometry from a known homotetramer complex to a monomeric form. Biochemical experiments using the MnSOD-K68Q Ac-mimic, or physically K68-Ac (MnSOD-K68-Ac), suggest that these monomers function as a peroxidase, distinct from the established MnSOD superoxide dismutase activity. MnSODK68Q expressing cells exhibit resistance to tamoxifen (Tam) and cells selected for Tam resistance exhibited increased K68-Ac and monomeric MnSOD. These results suggest a MnSOD-K68-Ac metabolic pathway for Tam resistance, carcinogenesis and tumor progression.",
author = "Yueming Zhu and Xianghui Zou and Dean, {Angela E.} and Brien, {Joseph O’} and Yucheng Gao and Tran, {Elizabeth L.} and Park, {Seong Hoon} and Guoxiang Liu and Kieffer, {Matthew B.} and Haiyan Jiang and Stauffer, {Melissa E.} and Robert Hart and Songhua Quan and Satchell, {Karla J. F.} and Nobuo Horikoshi and Marcelo Bonini and Gius, {David R}",
year = "2019",
month = "12",
day = "1",
doi = "10.1038/s41467-019-10352-4",
language = "English (US)",
volume = "10",
journal = "Nature Communications",
issn = "2041-1723",
publisher = "Nature Publishing Group",
number = "1",

}

Zhu, Y, Zou, X, Dean, AE, Brien, JO, Gao, Y, Tran, EL, Park, SH, Liu, G, Kieffer, MB, Jiang, H, Stauffer, ME, Hart, R, Quan, S, Satchell, KJF, Horikoshi, N, Bonini, M & Gius, DR 2019, 'Lysine 68 acetylation directs MnSOD as a tetrameric detoxification complex versus a monomeric tumor promoter', Nature communications, vol. 10, no. 1, 2399. https://doi.org/10.1038/s41467-019-10352-4

Lysine 68 acetylation directs MnSOD as a tetrameric detoxification complex versus a monomeric tumor promoter. / Zhu, Yueming; Zou, Xianghui; Dean, Angela E.; Brien, Joseph O’; Gao, Yucheng; Tran, Elizabeth L.; Park, Seong Hoon; Liu, Guoxiang; Kieffer, Matthew B.; Jiang, Haiyan; Stauffer, Melissa E.; Hart, Robert; Quan, Songhua; Satchell, Karla J. F.; Horikoshi, Nobuo; Bonini, Marcelo; Gius, David R.

In: Nature communications, Vol. 10, No. 1, 2399, 01.12.2019.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Lysine 68 acetylation directs MnSOD as a tetrameric detoxification complex versus a monomeric tumor promoter

AU - Zhu, Yueming

AU - Zou, Xianghui

AU - Dean, Angela E.

AU - Brien, Joseph O’

AU - Gao, Yucheng

AU - Tran, Elizabeth L.

AU - Park, Seong Hoon

AU - Liu, Guoxiang

AU - Kieffer, Matthew B.

AU - Jiang, Haiyan

AU - Stauffer, Melissa E.

AU - Hart, Robert

AU - Quan, Songhua

AU - Satchell, Karla J. F.

AU - Horikoshi, Nobuo

AU - Bonini, Marcelo

AU - Gius, David R

PY - 2019/12/1

Y1 - 2019/12/1

N2 - Manganese superoxide dismutase (MnSOD) functions as a tumor suppressor; however, once tumorigenesis occurs, clinical data suggest MnSOD levels correlate with more aggressive human tumors, implying a potential dual function of MnSOD in the regulation of metabolism. Here we show, using in vitro transformation and xenograft growth assays that the MnSOD-K68 acetylation (Ac) mimic mutant (MnSODK68Q) functions as a tumor promoter. Interestingly, in various breast cancer and primary cell types the expression of MnSODK68Q is accompanied with a change of MnSOD’s stoichiometry from a known homotetramer complex to a monomeric form. Biochemical experiments using the MnSOD-K68Q Ac-mimic, or physically K68-Ac (MnSOD-K68-Ac), suggest that these monomers function as a peroxidase, distinct from the established MnSOD superoxide dismutase activity. MnSODK68Q expressing cells exhibit resistance to tamoxifen (Tam) and cells selected for Tam resistance exhibited increased K68-Ac and monomeric MnSOD. These results suggest a MnSOD-K68-Ac metabolic pathway for Tam resistance, carcinogenesis and tumor progression.

AB - Manganese superoxide dismutase (MnSOD) functions as a tumor suppressor; however, once tumorigenesis occurs, clinical data suggest MnSOD levels correlate with more aggressive human tumors, implying a potential dual function of MnSOD in the regulation of metabolism. Here we show, using in vitro transformation and xenograft growth assays that the MnSOD-K68 acetylation (Ac) mimic mutant (MnSODK68Q) functions as a tumor promoter. Interestingly, in various breast cancer and primary cell types the expression of MnSODK68Q is accompanied with a change of MnSOD’s stoichiometry from a known homotetramer complex to a monomeric form. Biochemical experiments using the MnSOD-K68Q Ac-mimic, or physically K68-Ac (MnSOD-K68-Ac), suggest that these monomers function as a peroxidase, distinct from the established MnSOD superoxide dismutase activity. MnSODK68Q expressing cells exhibit resistance to tamoxifen (Tam) and cells selected for Tam resistance exhibited increased K68-Ac and monomeric MnSOD. These results suggest a MnSOD-K68-Ac metabolic pathway for Tam resistance, carcinogenesis and tumor progression.

UR - http://www.scopus.com/inward/record.url?scp=85066601943&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066601943&partnerID=8YFLogxK

U2 - 10.1038/s41467-019-10352-4

DO - 10.1038/s41467-019-10352-4

M3 - Article

VL - 10

JO - Nature Communications

JF - Nature Communications

SN - 2041-1723

IS - 1

M1 - 2399

ER -